Vagus Nerve Stimulation for POTS: What Research Shows
Vagus nerve stimulation for POTS is a research area, not an established POTS treatment. POTS affects the automatic adjustments that help maintain circulation when you stand. Because the vagus nerve participates in brain-body signaling and heart-rate regulation, researchers are testing whether noninvasive stimulation can influence some of those pathways. That is a reasonable question to investigate. It is not the same as showing that POTS is a vagus nerve disorder or that a device can cure it.
The most directly relevant trial so far was small: 26 women with POTS were randomized to active ear stimulation or sham stimulation for two months. The active group had a lower standing heart-rate increase at follow-up. The result is encouraging, but it needs replication in larger, more diverse groups and over a longer period before it changes routine care. This article explains the rationale, the evidence, and the decisions that still belong with a POTS clinician.([3])

What Is the Connection Between POTS and the Autonomic Nervous System?
The autonomic nervous system manages tasks that do not require conscious effort, including heart rate, blood-vessel tone, sweating, digestion, and rapid cardiovascular adjustments after standing. When a person stands, blood shifts toward the legs and abdomen. Sensors and reflexes normally tighten blood vessels, adjust heart rate, and help maintain blood flow to the brain.
POTS is a syndrome of chronic orthostatic intolerance. Diagnostic criteria involve a sustained rise in heart rate after standing, with symptoms such as lightheadedness, palpitations, fatigue, shakiness, nausea, or cognitive fog, and without the blood-pressure fall that defines orthostatic hypotension. The 2015 Heart Rhythm Society statement describes several possible contributors, including low blood volume, inadequate vasoconstriction, peripheral nerve changes, and altered sympathetic regulation. Different people can have different combinations.([2])
That variety matters. POTS is not explained by one injured nerve, and it should not be reduced to “low vagal tone.” A test, symptom pattern, medication plan, fluid and salt guidance, compression strategy, and exercise plan all need to be individualized by a qualified clinician.
Sympathetic and Parasympathetic Activity Are Not Simple Opposites
The sympathetic system helps mobilize cardiovascular responses. The parasympathetic system, in which the vagus nerve is important, participates in beat-to-beat regulation and recovery. Both systems work in feedback loops; Neither is simply good or bad. Some POTS research reports altered sympathetic activity or autonomic balance, but that does not mean every person has the same pattern or that increasing one signal is a universal solution.
Why Are Researchers Studying Vagus Nerve Stimulation for POTS?
The vagus nerve carries signals in both directions between the brainstem and organs. Most vagal fibers are afferent: they carry information from the body toward the brain. This is why vagus nerve stimulation is better understood as neuromodulation of a communication pathway than as a switch that simply turns on relaxation.
In transcutaneous auricular vagus nerve stimulation, or taVNS, a small electrical current is delivered through the skin of selected parts of the outer ear. Researchers study the auricular branch of the vagus nerve as a possible entry point to brainstem networks, including the nucleus tractus solitarius (NTS). The exact nerves recruited, downstream effects, and best stimulation settings are still being studied. Ear anatomy and stimulation parameters vary, so “ear stimulation” is not one uniform intervention.([1,4])

Figure 1. Two proposed routes by which stimulation of the auricular branch of the vagus nerve may influence parasympathetic activity. Reproduced unchanged from Figure 5 in Butt MF, Albusoda A, Farmer AD, Aziz Q. The anatomical basis for transcutaneous auricular vagus nerve stimulation. Journal of Anatomy. 2020;236(4):588-611.
Why the Outer Ear Is Studied
The outer ear is accessible without surgery. That makes taVNS different from implanted cervical VNS, where a pulse generator and electrodes are placed surgically around the vagus nerve in the neck. A noninvasive approach may be easier to study, but it does not prove that it has the same physiologic effects as implanted VNS. The anatomical review by Butt and colleagues also emphasizes uncertainty: the sensory map of the ear is variable, and nearby non-vagal nerves may be activated.([1])
What Does Current Research Say About Vagus Nerve Stimulation for POTS?
The POTS-specific evidence is promising but preliminary. In the 2024 randomized, double-blind, sham-controlled trial by Stavrakis and colleagues, participants used active tragus stimulation or sham earlobe stimulation for one hour daily for two months. At the final visit, the active group had a smaller average increase in heart rate during the postural test than the sham group (17.6 versus 31.7 beats per minute; P = .01). The investigators also reported changes in selected inflammatory markers, autoantibody measures, and short ECG-based heart-rate-variability measures. No device-related adverse events were reported during follow-up.([3])
The study cannot establish a standard protocol. It enrolled only 26 people, all participants were women, follow-up was short, and patients continued their existing POTS medications. Its autonomic symptom questionnaire result trended in favor of active stimulation but was not statistically significant. A lower standing heart-rate response in this trial is not the same as proven relief of every POTS symptom, durable improvement, or effectiveness for every POTS subtype.
A useful way to read this evidence is: it supports a hypothesis worth testing, not a reason to replace established evaluation or care. Studies also use different ear sites, waveforms, intensities, session lengths, controls, and outcome measures. Those differences make it hard to compare results or identify who is most likely to benefit.
The choice of sham condition is another reason to stay careful. The earlobe is often used as a comparison site, but the outer ear contains multiple sensory nerves and electrical stimulation at a “sham” site may not be completely inert. At the same time, sensations from an active ear clip can make blinding difficult. Those are ordinary challenges in device research, not proof that the study is invalid. They do mean that a single trial is only one step in building an evidence base.([1,4])
For a stronger answer, future studies need to enroll larger and more varied groups, describe POTS subtypes clearly, track meaningful symptoms and daily function as well as heart-rate changes, and follow participants long enough to assess durability and adverse effects. They also need reproducible stimulation details. Frequency, pulse width, current intensity, ear location, daily exposure, and the participant’s sensation threshold can all change the intervention being tested.

Figure 2. A hypothesized brainstem pathway through which auricular stimulation may influence cardiovascular regulation. Reproduced unchanged from Figure 6 in Butt MF, Albusoda A, Farmer AD, Aziz Q. The anatomical basis for transcutaneous auricular vagus nerve stimulation. Journal of Anatomy. 2020;236(4):588-611.
Does Vagus Nerve Stimulation Affect HRV?
Heart-rate variability, or HRV, describes variation between heartbeats. It can be useful in research, but it is not a direct meter of vagus nerve activity or a score of nervous-system health. Breathing, posture, time of day, medication, illness, and analysis method can all affect it. In POTS research, HRV is one physiologic measure among several. A change in HRV should not be used alone to diagnose POTS, decide that a device is working, or guide medication changes.([1,3])
What Types of Vagus Nerve Stimulation Are Used or Studied?
Implanted VNS and transcutaneous VNS are different technologies with different risk profiles. Implanted VNS is a surgical therapy used in specific clinical settings, such as certain treatment-resistant epilepsy or depression indications. It is not a routine POTS intervention. Surgery and direct cervical stimulation introduce risks that do not apply in the same way to external ear devices.([1])
taVNS is the most relevant category for POTS research because it is external and ear-based. It should still be treated as a device intervention with a protocol, contraindications, and limits, not as a generic wellness practice. A product may use the phrase “vagus nerve stimulation” while using settings that differ from a clinical study. Evidence for one device, site, dose, and population does not automatically transfer to another.
Can Vagus Nerve Exercises Support People With POTS?
Slow, comfortable breathing, relaxation practices, and gentle movement can help some people notice tension and pace activity. They may be useful parts of a clinician-approved routine, especially when symptoms are stable. They do not treat the underlying causes of POTS, and a breathing exercise should not be used to push through presyncope, chest pain, or severe palpitations. For people with exercise intolerance, an individualized plan often starts with recumbent or seated movement rather than upright exertion.
Choosing a Vagus Nerve Stimulation Device: What Should You Consider?
If you are considering an ear-based wellness device, start with the gap between its marketing and the evidence. Ask whether the claimed use matches a studied population, site, intensity, frequency, and outcome. Look for transparent instructions, comfort, skin-contact safety, return policies, and a plan to discuss the device with the clinician who manages your POTS. Do not assume an HRV display proves a treatment effect.

ZenoWell Luna Plus is an ear-based, noninvasive wellness device intended to support relaxation and nervous-system-focused routines. It may fit someone who wants a consistent relaxation practice, but it should not be presented as a treatment for POTS, a way to normalize heart rate, or a substitute for medical assessment. Use only as directed and bring product details to your clinician if you have POTS or another heart-rhythm concern.
A practical decision rule is simple: do not change prescribed fluids, salt, compression, exercise, or medication because a consumer device seems helpful for a few sessions. If you choose to try a wellness device after medical guidance, track the experience conservatively. Note the session setting, symptoms, posture, and any skin irritation or dizziness. Stop and seek advice if symptoms worsen. This protects against confusing a temporary change in symptoms with a reliable treatment effect.
When Should People With POTS Seek Medical Guidance?
Talk with a clinician before starting electrical stimulation if you have POTS, especially if you have a cardiac device, a known arrhythmia, unexplained fainting, pregnancy, seizures, significant ear or skin problems, or a complex medication regimen. A clinician can help distinguish POTS from other causes of rapid heart rate and decide whether a device is appropriate in the context of your care plan.
Seek urgent medical evaluation for chest pain, severe shortness of breath, new neurologic symptoms, injury after fainting, or persistent palpitations with concerning symptoms. If symptoms are worsening or different from your usual POTS pattern, do not assume a vagus-focused routine is the answer.
Frequently Asked Questions
Can vagus nerve stimulation cure POTS?
No. Vagus nerve stimulation is not an established cure or standard treatment for POTS. Current studies explore autonomic modulation and require larger, longer trials.
Is POTS caused by vagus nerve problems?
No single vagus nerve problem explains POTS. POTS involves a broader set of autonomic and cardiovascular regulatory pathways, and contributors differ between people.
Can tVNS help POTS symptoms?
A small sham-controlled trial found a lower standing heart-rate increase after two months of active stimulation, but it did not establish broad symptom relief or long-term effectiveness. Discuss any device with your POTS clinician.
Is HRV proof that stimulation is working?
No. HRV is influenced by many factors and is not a standalone measure of vagus nerve activity, POTS severity, or treatment response.
Sources
[1] Butt MF, Albusoda A, Farmer AD, Aziz Q. The anatomical basis for transcutaneous auricular vagus nerve stimulation. Journal of Anatomy. 2020;236(4):588-611. doi:10.1111/joa.13122.
[2] Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12(6):e41-e63. doi:10.1016/j.hrthm.2015.03.029.
[3] Stavrakis S, Chakraborty P, Farhat K, et al. Noninvasive vagus nerve stimulation in postural tachycardia syndrome: A randomized clinical trial. JACC: Clinical Electrophysiology. 2024;10(2):346-355. doi:10.1016/j.jacep.2023.10.015.
[4] Farmer AD, Strzelczyk A, Finisguerra A, et al. International consensus based review and recommendations for minimum reporting standards in research on transcutaneous vagus nerve stimulation (Version 2020). Frontiers in Human Neuroscience. 2020;14:568051. doi:10.3389/fnhum.2020.568051.